Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain.
Research Laboratory CELLEX, Hospital Clínic Barcelona, Barcelona, Spain, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBER de Enfermedades Respiratorias (CIBERES), University of Barcelona, Barcelona, Spain.
Am J Health Syst Pharm. 2021 Jul 22;78(15):1444-1447. doi: 10.1093/ajhp/zxab195.
To evaluate the stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution (BSS) and stored at -20°C in polypropylene containers.
Six batches of vancomycin 50 mg/mL eyedrops were aseptically prepared. One bottle of each batch was analyzed immediately after preparation, and the rest were stored at -20°C and analyzed using high-performance liquid chromatography (HPLC) at 30, 60, and 90 days to test their physicochemical stability and sterility. Thereafter, bottles were removed from the freezer and stored at 5°C for 30 days, with HPLC and other analyses repeated 105 and 120 days after preparation. All samples were analyzed in triplicate. Stability was defined as the absence of particles, color variation, or changes in pH and a remaining vancomycin concentration of 90% to 110% of the initial concentration. The sterility of the ophthalmic solution was evaluated by using soybean-casein digest broth with resins; samples were incubated for 7 days and checked daily for signs of microbial growth.
There was no particle formation or sign of precipitation in any of the solutions throughout the duration of the study, regardless of the storage conditions. No change in color or turbidity was observed. The pH and osmolarity remained unchanged during storage at -20°C and after thawing. The vancomycin concentration remained within 10% of the initial concentration during the 90-day period of storage at -20°C and the subsequent 30 days after thawing. Sterility was preserved in all samples.
A 5% solution of vancomycin prepared using BSS was physicochemically and microbiologically stable when stored at -20°C for 90 days. After thawing, this extemporaneous formulation remained stable when refrigerated at 5°C for 30 days.
评估使用平衡盐溶液(BSS)制备的 5%万古霉素眼科溶液在-20°C 下储存在聚丙烯容器中的稳定性。
无菌制备 6 批 50mg/mL 的万古霉素滴眼剂。每批的一瓶立即进行分析,其余的储存在-20°C 下,并在 30、60 和 90 天使用高效液相色谱(HPLC)进行分析,以测试其物理化学稳定性和无菌性。此后,将瓶子从冷冻室中取出并在 5°C 下储存 30 天,在制备后 105 和 120 天重复进行 HPLC 和其他分析。所有样品均进行了三倍分析。稳定性定义为无颗粒形成、颜色变化或 pH 值变化,且万古霉素浓度保持在初始浓度的 90%至 110%之间。通过使用含树脂的大豆酪蛋白消化肉汤评估眼科溶液的无菌性;将样品孵育 7 天,并每天检查是否有微生物生长的迹象。
在整个研究过程中,无论存储条件如何,所有溶液均未出现颗粒形成或沉淀的迹象。未观察到颜色或浊度变化。在-20°C 下储存和解冻后,pH 值和渗透压保持不变。在-20°C 下储存 90 天期间以及解冻后 30 天内,万古霉素浓度保持在初始浓度的 10%以内。所有样品均保持无菌。
使用 BSS 制备的 5%万古霉素溶液在-20°C 下储存 90 天时在物理化学和微生物学上是稳定的。解冻后,在 5°C 冷藏 30 天时,这种临时制剂仍然稳定。